Experimental Pill Promises New Hope for Deadly Pancreatic Cancer

A novel pill helped people with advanced pancreatic cancer live longer, raising hopes of long-needed better treatments for one of the deadliest types of cancer. Researchers reported that the experimental drug significantly improved survival rates, offering a breakthrough in oncology. This development represents a critical step forward in the fight against a disease that has historically had few effective treatment options.